Enhancing Bond Strength Of Medical Devices

US2018086902A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018086902-A1
Application numberUS-201715711646-A
CountryUS
Kind codeA1
Filing dateSep 21, 2017
Priority dateSep 26, 2016
Publication dateMar 29, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Components of medical devices include polyethylene-poly(ethylene oxide) amphiphilic graft copolymers (PE-g-PEO) in their base polymer formulations. The base polymeric formulations comprise at least a polymer or co-polymer of ethylene. These components are suitable for solvent-bonding with other components and enhance bond strength of the medical devices.

First claim

Opening claim text (preview).

What is claimed is: 1 . A tubing for a medical device formed from a blend comprising: a base polymeric formulation comprising at least a polymer or co-polymer of ethylene or propylene and excluding free poly(ethylene oxide); and an additive comprising a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO); the PE-g-PEO being present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend. 2 . The tubing of claim 1 , wherein the PE-g-PEO is according to Formula (I): wherein R is hydrogen, alkyl, substituted alkyl, vinylic substituted alkyl, hydrocarbyl, substituted hydrocarbyl, or vinylic substituted hydrocarbyl group; the molar value of m is in the range from 2 to 40 mole percent; the molar value of n is in the range from 60 to 98 mole percent; and p is in the range from 5 to 500 ethylene oxide units. 3 . The tubing of claim 1 , wherein the base polymeric formulation comprises polyethylene, polypropylene, a polyethylene-polypropylene co-polymer, a polyethylene- and/or polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 4 . The tubing of claim 3 , wherein the base polymeric formulation comprises a co-polymer of polyethylene and polypropylene. 5 . The tubing of claim 3 , wherein the polyethylene-and/or polypropylene-containing thermoplastic elastomer (TPE) comprises at least 60 mol % total polyethylene and/or polypropylene. 6 . The tubing of claim 1 , wherein the PE-g-PEO is a product of ethylene oxide ring-opening polymerization of an ethylene vinyl acetate copolymer having from 10 to 40 weight percent of vinyl acetate. 7 . The tubing of claim 1 , wherein the PE-g-PEO has a dispersity index in the range of 2 to 10. 8 . A medical device comprising: a tubing comprising a polymeric blend comprising a base polymeric formulation comprising at least a polymer or co-polymer of ethylene or propylene and excluding free poly(ethylene oxide), and an additive comprising a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO) according to Formula (I): wherein R is hydrogen, alkyl, substituted alkyl, vinylic substituted alkyl, hydrocarbyl, substituted hydrocarbyl, or vinylic substituted hydrocarbyl group; the molar value of m is in the range from 2 to 40 mole percent; the molar value of n is in the range from 60 to 98 mole percent; and p is in the range from 5 to 500 ethylene oxide units; wherein the PE-g-PEO is present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend; and a connector bonded to the tubing; wherein the PE-g-PEO is effective to enhance bonding of the tubing to a connector. 9 . The medical device of claim 8 , wherein the base polymeric formulation comprises polyethylene, polypropylene, a polyethylene-polypropylene co-polymer, a polyethylene- and/or polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 10 . The medical device of claim 8 , wherein the base polymeric formulation comprises a co-polymer of polyethylene and polypropylene. 11 . The medical device of claim 8 , wherein the polyethylene-and/or polypropylene-containing thermoplastic elastomer (TPE) comprises at least 60 mol % polyethylene and/or polypropylene. 12 . The medical device of claim 8 , wherein the PE-g-PEO is a product of ethylene oxide ring-opening polymerization of an ethylene vinyl acetate copolymer having from 10 to 40 weight percent of vinyl acetate. 13 . The medical device of claim 8 , wherein the connector comprises a polar material. 14 . The medical device of claim 13 , wherein the polar material selected from the group consisting of: poly(methyl methacrylate) (PMMA), styrene maleic anhydride (SMA), polycarbonate (PC), and methyl methacrylate-acrylonitrile-butadiene-styrene (MABS). 15 . The medical device of claim 8 , wherein the connector is solvent-bonded to the tubing. 16 . A method of making a medical device comprising: obtaining a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO); combining the PE-g-PEO with a base polymeric formulation comprising at least a polymer or co-polymer of ethylene or propylene and excluding free poly(ethylene oxide) to form a blend, the PE-g-PEO being present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend; forming a tubing from the blend; and bonding the tubing to a connector in the presence of a solvent to form the medical device; wherein the PE-g-PEO is effective to enhance bonding of the tubing to a connector. 17 . The method of claim 16 , wherein ethylene oxide ring-opening polymerization of an ethylene vinyl acetate copolymer having from 10 to 40 weight percent of vinyl acetate is used to form the PE-g-PEO, which is according to Formula (I): wherein R is hydrogen, alkyl, substituted alkyl, vinylic substituted alkyl, hydrocarbyl, substituted hydrocarbyl, or vinylic substituted hydrocarbyl group; the molar value of m is in the range from 2 to 40 mole percent; the molar value of n is in the range from 60 to 98 mole percent; and p is in the range from 5 to 500 ethylene oxide units. 18 . The method of claim 16 , wherein the base polymeric formulation comprises polyethylene, polypropylene, a polyethylene-polypropylene co-polymer, a polyethylene- and/or polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 19 . The method of claim 16 , wherein the base polymeric formulation comprises a co-polymer of polyethylene and polypropylene. 20 . The method of claim 16 , wherein the polyethylene-and/or polypropylene-containing thermoplastic elastomer (TPE) comprises at least 60 mol % polyethylene and/or polypropylene.

Assignees

Inventors

Classifications

  • C08L23/06Primary

    Polyethylene · CPC title

  • LDPE (radical process) · CPC title

  • used for pipes · CPC title

  • specially adapted for joining pipes of dissimilar materials {(joints between metal and plastic pipes F16L47/24)} · CPC title

  • A61L29/049Primary

    Mixtures of macromolecular compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018086902A1 cover?
Components of medical devices include polyethylene-poly(ethylene oxide) amphiphilic graft copolymers (PE-g-PEO) in their base polymer formulations. The base polymeric formulations comprise at least a polymer or co-polymer of ethylene. These components are suitable for solvent-bonding with other components and enhance bond strength of the medical devices.
Who is the assignee on this patent?
Becton Dickinson Co
What technology area does this patent fall under?
Primary CPC classification C08L23/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Mar 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).